Lake Street Capital Markets Starts Arcadia Biosciences (RKDA) at Buy

Lake Street Capital Markets initiates coverage on Arcadia Biosciences (NASDAQ: RKDA) with a Buy rating and a price target of $4.50.

For an analyst ratings summary and ratings history on Arcadia Biosciences click here. For more ratings news on Arcadia Biosciences click here.

Shares of Arcadia Biosciences closed at $2.50 yesterday.

You May Also Be Interested In

• UPDATE: Raymond James Assumes Vulcan Materials Company (VMC) with a Outperform
• Arcadia Biosciences (RKDA) Prices 4.72M Share Offering at $1.06/sh
• UPDATE: Raymond James Assumes Eagle Materials (EXP) with a Outperform